Cigna Corp (CI) Receives $232.86 Average PT from Brokerages

Shares of Cigna Corp (NYSE:CI) have earned a consensus rating of “Buy” from the eighteen research firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and fifteen have given a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $228.73.

A number of research firms have commented on CI. Barclays cut their target price on shares of Cigna from $220.00 to $207.00 and set an “overweight” rating for the company in a research report on Wednesday, April 17th. Zacks Investment Research downgraded shares of Cigna from a “hold” rating to a “sell” rating in a research report on Tuesday, April 16th. ValuEngine downgraded shares of Cigna from a “sell” rating to a “strong sell” rating in a research report on Thursday, April 18th. UBS Group began coverage on shares of Cigna in a research report on Tuesday, April 23rd. They issued a “buy” rating and a $185.00 target price for the company. Finally, Goldman Sachs Group downgraded shares of Cigna from a “conviction-buy” rating to a “buy” rating in a research report on Friday, May 3rd.

In other news, insider Brian C. Evanko bought 2,000 shares of the stock in a transaction that occurred on Monday, March 11th. The shares were bought at an average price of $163.40 per share, for a total transaction of $326,800.00. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William D. Zollars sold 272 shares of Cigna stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $168.43, for a total transaction of $45,812.96. The disclosure for this sale can be found here. Company insiders own 0.80% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. 1 North Wealth Services LLC bought a new stake in shares of Cigna in the 4th quarter worth about $25,000. Clarfeld Financial Advisors LLC bought a new stake in shares of Cigna in the 4th quarter worth about $25,000. Private Ocean LLC bought a new stake in shares of Cigna in the 4th quarter worth about $26,000. Delta Asset Management LLC TN bought a new stake in shares of Cigna in the 4th quarter worth about $28,000. Finally, Litman Gregory Asset Management LLC bought a new stake in shares of Cigna in the 4th quarter worth about $30,000. Institutional investors own 88.61% of the company’s stock.

Shares of CI traded down $0.71 on Friday, hitting $154.58. 52,187 shares of the stock traded hands, compared to its average volume of 3,328,440. The company has a market capitalization of $58.93 billion, a P/E ratio of 10.86, a price-to-earnings-growth ratio of 0.78 and a beta of 0.69. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.89. Cigna has a one year low of $141.95 and a one year high of $226.60.

Cigna (NYSE:CI) last announced its quarterly earnings results on Thursday, May 2nd. The health services provider reported $3.90 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.74 by $0.16. Cigna had a net margin of 4.11% and a return on equity of 14.23%. The company had revenue of $33.43 billion during the quarter, compared to the consensus estimate of $32.79 billion. During the same quarter last year, the firm earned $4.11 earnings per share. The firm’s quarterly revenue was up 192.9% compared to the same quarter last year. On average, sell-side analysts expect that Cigna will post 16.54 EPS for the current year.

Cigna Company Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Story: What is a short straddle?

Analyst Recommendations for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.